Mind Medicine To Raise Further $19.5 Million In Bought Deal
Mind Medicine (NEO: MMED) this morning announced that it is conducting yet another round of financing, after having raised $92.1
Read moreMind Medicine (NEO: MMED) this morning announced that it is conducting yet another round of financing, after having raised $92.1
Read morePure Extracts (CSE: PULL) continues to focus on the development of its mushroom-related operations in addition to cannabis. The company
Read moreMind Cure Health (CSE: MCUR) this morning announced that it has begun the first stage of the manufacture of pharmaceutical
Read morePsyched Wellness (CSE: PSYC) this morning issued a brief press release related to the ongoing pre-clinical trial of its muscimol
Read morePharmaTher Inc (CSE: PHRM) this morning announced that it will be conducting further research related to psychedelics. The company this
Read moreMind Cure Health (CSE: MCUR) this morning announced the appointment of Rob Hill to the firms board of directors. The
Read moreMindMed (NEO: MMED) this morning announced that it will be acquiring that of HealthMode in a largely stock-based transaction. HealthMode
Read moreMind Cure Health (CSE: MCUR) continued its constant roll of news this week, announcing this morning that it has launched
Read morePsyched Wellness (CSE: PSYC) has closed its previously announced private placement. The company managed to raise an impressive $6.6 million
Read morePharmaTher (CSE: PHRM) has seen the completion of the sale of its psilocybin program to that of Revive Therapeutics (CSE:
Read more